title: The H3 antagonist thioperamide reveals conditioned preference for a context associated with an inactive small dose of cocaine in C57BL/6J mice.
abstract: The histaminergic system has been speculated to be involved in the inhibitory control of drug reward, H1 and H2 antagonists having been found to potentiate conditioned place preference induced by morphine or cocaine. In contrast, the role of H3 receptors in cocaine-induced place preference is still unknown. The present study tested the effects of thioperamide (0, 10 and 20 mg/kg, i.p.), an H3 autoreceptor antagonist, on the development of a conditioned place preference induced by cocaine (0, 2 and 8 mg/kg, i.p.) in C57BL/6J mice. Thioperamide was injected 10 min before each cocaine-pairing session. The activity scores recorded on the first cocaine-pairing session were also used to test the effects of thioperamide on cocaine-induced locomotor activity. Thioperamide alone had no reinforcing effects and did not affect the conditioned place preference induced by 8 mg/kg cocaine. However, thioperamide dose-dependently revealed a conditioned place preference induced by 2 mg/kg cocaine, a dose that was inactive per se. Finally, thioperamide dose-dependently potentiated the stimulant effects of cocaine, in spite of its slight hypolocomotor effect when given alone. Our results strongly suggest that H3 antagonists potentiate the stimulant and reinforcing effects of cocaine in mice.
authors.affiliation: Behavioural Neuroscience and Psychopharmacology Laboratory, University of Liège, Liège, Belgium.
authors.forename: Christian
authors.initials: C
authors.lastname: Brabant
authors.forename: Yana
authors.initials: Y
authors.lastname: Charlier
authors.forename: Etienne
authors.initials: E
authors.lastname: Quertemont
authors.forename: Ezio
authors.initials: E
authors.lastname: Tirelli
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001522:Behavior, Animal; D003042:Cocaine / Q000494:pharmacology*; D003216:Conditioning, Operant / Q000187:drug effects*; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006633:Histamine Antagonists / Q000494:pharmacology*; D008124:Locomotion / Q000187:drug effects; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010880:Piperidines / Q000494:pharmacology*; D018100:Receptors, Histamine H3 / Q000378:metabolism*; D012054:Reinforcement, Psychology
chemical_list: D018765:Dopamine Uptake Inhibitors; D006633:Histamine Antagonists; D010880:Piperidines; D018100:Receptors, Histamine H3; D003042:Cocaine; C052075:thioperamide